Suppr超能文献

I50V 突变体和 I50L/A71V 双突变 HIV 蛋白酶与抑制剂 TMC114(达芦那韦)的相互作用:分子动力学模拟和结合自由能研究。

Interaction of I50V mutant and I50L/A71V double mutant HIV-protease with inhibitor TMC114 (darunavir): molecular dynamics simulation and binding free energy studies.

机构信息

Computational Chemistry Laboratory, Department of Natural Sciences, Albany State University, Albany, Georgia 31705, USA.

出版信息

J Phys Chem B. 2012 Feb 16;116(6):1884-900. doi: 10.1021/jp2074804. Epub 2012 Feb 3.

Abstract

In the present work, the binding of inhibitor TMC114 (darunavir) to wild-type (WT), single (I50V) as well as double (I50L/A71V) mutant HIV-proteases (HIV-pr) was investigated with all-atom molecular dynamics (MD) simulations as well as molecular mechanic-Poisson-Boltzmann surface area (MM-PBSA) calculation. For both the apo and complexed HIV-pr, many intriguing effects due to double mutant, I50L/A71V, are observed. For example, the flap-flap distance and the distance from the active site to the flap residues in the apo I50L/A71V-HIV-pr are smaller than those of WT- and I50V-HIV-pr, probably making the active site smaller in volume and closer movement of flaps. For the complexed HIV-pr with TMC114, the double mutant I50L/A71V shows a less curling of the flap tips and less flexibility than WT and the single mutant I50V. As for the other previous studies, the present results also show that the single mutant I50V decreases the binding affinity of I50V-HIV-pr to TMC, resulting in a drug resistance; whereas the double mutant I50L/A71V increases the binding affinity, and as a result of the stronger binding, the I50L/A71V may be well adapted by the TMC114. The energy decomposition analysis suggests that the increase of the binding for the double mutant I50L/A71V-HIV-pr can be mainly attributed to the increase in electrostatic energy by -5.52 kacl/mol and van der Waals by -0.42 kcal/mol, which are canceled out in part by the increase of polar solvation energy of 1.99 kcal/mol. The I50L/A71V mutant directly increases the binding affinity by approximately -0.88 (Ile50 to Leu50) and -0.90 (Ile50' to Leu50') kcal/mol, accounting 45% for the total gain of the binding affinity. Besides the direct effects from the residues Leu50 and Leu50', the residue Gly49' increases the binding affinity of I50L/A71V-HIV-pr to the inhibitor by -0.74 kcal/mol, to which the electrostatic interaction of Leu50's backbone contributes by -1.23 kcal/mol. Another two residues Ile84 and Ile47' also increase the binding affinity by -0.22 and -0.29 kcal/mol, respectively, which can be mainly attributed to van der Waals terms (ΔT(vdw) = -0.21 and -0.39 kcal/mol).

摘要

在本工作中,通过全原子分子动力学(MD)模拟以及分子力学-泊松-玻尔兹曼表面积(MM-PBSA)计算研究了抑制剂 TMC114(达芦那韦)与野生型(WT)、单突变体(I50V)以及双突变体(I50L/A71V)HIV 蛋白酶(HIV-pr)的结合。对于无配体和配体结合的 HIV-pr,观察到许多由于双突变体 I50L/A71V 引起的有趣效应。例如,无配体 I50L/A71V-HIV-pr 的瓣-瓣距离和活性位点到瓣残基的距离小于 WT 和 I50V-HIV-pr,可能使活性位点体积更小,瓣的运动更接近。对于与 TMC114 结合的复合物 HIV-pr,双突变体 I50L/A71V 显示出比 WT 和单突变体 I50V 更少的瓣尖卷曲和更大的灵活性。与之前的其他研究一样,本研究结果还表明,单突变体 I50V 降低了 I50V-HIV-pr 与 TMC 的结合亲和力,导致耐药性;而双突变体 I50L/A71V 增加了结合亲和力,并且由于更强的结合,I50L/A71V 可能被 TMC114 很好地适应。能量分解分析表明,双突变体 I50L/A71V-HIV-pr 结合的增加主要归因于静电能增加了-5.52 kacl/mol 和范德华能增加了-0.42 kcal/mol,部分被极性溶剂化能增加 1.99 kcal/mol 抵消。I50L/A71V 突变体通过大约-0.88(Ile50 到 Leu50)和-0.90(Ile50' 到 Leu50')kcal/mol 直接增加结合亲和力,占结合亲和力总增益的 45%。除了残基 Leu50 和 Leu50' 的直接影响外,残基 Gly49' 通过-0.74 kcal/mol 增加了 I50L/A71V-HIV-pr 与抑制剂的结合亲和力,其中 Leu50 的骨架静电相互作用贡献了-1.23 kcal/mol。另外两个残基 Ile84 和 Ile47' 也分别通过-0.22 和-0.29 kcal/mol 增加了结合亲和力,这主要归因于范德华项(ΔT(vdw) = -0.21 和-0.39 kcal/mol)。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验